Morocco medicine price database

METHOTREXATE MYLAN

METHOTREXATE

Public price

1.392,00 MAD

Reimbursement base

1.392,00 MAD

Active substance

METHOTREXATE

Reimbursable

What is this medicine?

A dihydrofolate reductase inhibitor that interferes with DNA synthesis, repair, and cellular replication.

Verified summary

METHOTREXATE, SOLUTION INJECTABLE, 5 G, 1 FLACON 200 ML

Common uses

Acute lymphoblastic leukemia (ALL),Mycosis fungoides,Relapsed or refractory non-Hodgkin lymphoma,Rheumatoid arthritis,Polyarticular juvenile idiopathic arthritis (pJIA),Severe psoriasis

Class

Dihydrofolate reductase inhibitor

Availability note

Reimbursable

Hospital price

1.124,00 MAD

Strength

5 G

Form

SOLUTION INJECTABLE

Presentation

1 FLACON 200 ML

Type

G

Therapeutic class

ANTINEOPLASIQUE CYTOTOXIQUE

This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.

Price history

Reference price recorded since 2017-12-18: 1.392,00 MAD

Available presentations and strengths

Medicines with the same active substance